The Bigfoot Unity System uses iCGM data from Abbott’s FreeStyle Libre 2 system and consists of smart pen caps for rapid- and long-acting insulin, as well as a mobile app.
Chronic constipation affects up to 60% of patients with diabetes adding stress to an already potentially fatal condition. Here, we highlight an ongoing systemic review of acupuncture as relief from chronic constipation.
Foot ulcers and infections affect up to 15% of patients with diabetes and 40% of these ulcers can become infected. In this featured study, researchers examine how often a patient with a foot ulcer is admitted to the hospital for treatment of an invasive bacterial infection.
Diabetes is associated with increased risk of vascular conditions, such as ischemic heart disease, stroke, renal, and neuropathic complications. In this featured study, researchers examine how the cause of mortality in diabetes has changed over time.
The researchers reviewed studies evaluating the effectiveness of minocycline in alleviating neuropathic pain because it reduces microglial activation, which suggests that it may reduce neuropathic pain.
In this study, researchers from the University of Pittsburgh share new findings that suggest women with type 1 diabetes have a shorter reproductive period and early menopause.
Study authors evaluated whether using an observational study that includes Medicare claims data could detect the proarrhythmic risk of medications known to prolong the QT interval.
Achieving glycemic control is important in preventing to prevent long-term type 1 diabetes complications. In this featured study, researchers investigate the use of hybrid closed-loop automated basal insulin delivery system.
Previous studies have shown that continuous subcutaneous insulin infusions can lead to improvements in clinical and quality of life benefits as compared to multiple daily injections of insulin. In this study, researchers led by Sanjeev Mehta, MD, MPH, of the Joslin Diabetes Center at Harvard University, test that concept in type 1 diabetes patients.
Patients with type 1 and type 2 diabetes have a high risk of cardiovascular disease (CVD), but now, a new study shows that type 1 diabetes patients are more susceptible to both cardiovascular and renal disease.
